The We Company (WE) isn’t SoftBank’s only dud. SoftBank has been a principal shareholder on two US IPOs this year, both of which are now underwater. This week’s IPO of Chinese software platform OneConnect Financial Technology (OCFT) would continue the streak. ...read more
At the end of each quarter, we look back at the most viewed profiles on IPO Pro. In 3Q 2019, the ten companies below – from a data monitoring and analytics provider, to an at-home fitness unicorn – have led the quarter and piqued the curiosity of IPO Pro customers. ...read more
Almost two-thirds of all IPOs in the 3Q were healthcare or tech, along with 7 of the top 10 best-performing IPOs. The healthcare sector had 14 offerings raise $4.0 billion; deal flow was driven by biotechs (7) and diagnostics companies (3), while two dental products makers represented about half of the sector’s proceeds. Three companies sold healthcare technology, two software...read more
The IPO Party Is Cut Short The third quarter started off in high spirits but ended with a hangover. During the quarter, 39 deals raised $10.8 billion, down slightly from last year, but above the historical average. Healthcare and tech companies again dominated IPO issuance. Software unicorns confirmed that there...read more
Hard times for SoftBank in the IPO market
The We Company (WE) isn’t SoftBank’s only dud. SoftBank has been a principal shareholder on two US IPOs this year, both of which are now underwater. This week’s IPO of Chinese software platform OneConnect Financial Technology (OCFT) would continue the streak. ...read more
The Top IPO Profiles on IPO Pro in 3Q 2019
At the end of each quarter, we look back at the most viewed profiles on IPO Pro. In 3Q 2019, the ten companies below – from a data monitoring and analytics provider, to an at-home fitness unicorn – have led the quarter and piqued the curiosity of IPO Pro customers. ...read more
Healthcare and Tech Industries Led IPO Activity in the 3Q
Almost two-thirds of all IPOs in the 3Q were healthcare or tech, along with 7 of the top 10 best-performing IPOs. The healthcare sector had 14 offerings raise $4.0 billion; deal flow was driven by biotechs (7) and diagnostics companies (3), while two dental products makers represented about half of the sector’s proceeds. Three companies sold healthcare technology, two software...read more
Renaissance Capital's 3Q 2019 US IPO Market Review
The IPO Party Is Cut Short The third quarter started off in high spirits but ended with a hangover. During the quarter, 39 deals raised $10.8 billion, down slightly from last year, but above the historical average. Healthcare and tech companies again dominated IPO issuance. Software unicorns confirmed that there...read more